ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,817Medicare Part D Prescriptions Filled, Including Refills

Rank: 189 out of 625

$649K Total Retail Price of All Prescriptions

Rank: 115 out of 625

563 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,365 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LEVOTHYROXINE SODIUM 346 337 1 3
ZOLPIDEM TARTRATE 331 323 2 13
PRAVASTATIN SODIUM 242 221 3 8
AMLODIPINE BESYLATE 231 227 4 1
SIMVASTATIN 209 205 5 2
ATORVASTATIN CALCIUM 189 176 6 9
ATENOLOL 156 140 7 22
METFORMIN HCL 149 126 8 10
DIOVAN 147 144 9 28
FUROSEMIDE 145 138 10 7
HYDROCODONE-ACETAMINOPHEN 143 125 S3 11 4
METOPROLOL SUCCINATE 139 133 12 15
CRESTOR 127 126 13 17
ZETIA 126 119 14 66
METHYLPREDNISOLONE 113 108 15 120
LOSARTAN POTASSIUM 109 109 16 18
OMEPRAZOLE 107 105 17 6
DIOVAN HCT 105 105 18 52
LISINOPRIL 101 94 19 5
LOSARTAN-HYDROCHLOROTHIAZIDE 99 99 20 38
TRAMADOL HCL 91 87 21 16
HYDROCHLOROTHIAZIDE 87 81 22 12
MELOXICAM 80 67 23 31
AZITHROMYCIN 77 71 24 40
DONEPEZIL HCL 77 77 24 33
POTASSIUM CHLORIDE 75 75 26 19
TRAZODONE HCL 73 73 27 51
BENICAR 71 71 28 143
CLOPIDOGREL 71 68 28 30
CIPROFLOXACIN HCL 67 65 30 60
TAMSULOSIN HCL 65 63 31 36
LEVOFLOXACIN 63 59 32 90
GABAPENTIN 63 38 32 14
CARVEDILOL 63 58 32 23
PRADAXA 61 61 35 284
CELEBREX 61 60 35 72
PREDNISONE 60 54 37 37
WARFARIN SODIUM 59 56 38 20
METOPROLOL TARTRATE 58 58 39 11
NIASPAN 56 49 40 101
FENOFIBRATE 53 52 41 59
MECLIZINE HCL 51 48 42 113
AMOXICILLIN 50 47 43 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.